EPIX Essa Pharma Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: EPIX

Price (delayed)

$1.77

Market cap

$78.57M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.69

Enterprise value

-$14.7M

as a clinical-stage pharmaceutical company founded on cutting-edge research, essa is focused on developing novel therapeutics for cancer patients. essa embraces innovation not only in our products but also in ...

Highlights
The company's debt fell by 19% YoY and by 7% QoQ
The net income has contracted by 21% YoY and by 9% from the previous quarter
EPIX's quick ratio is down by 19% year-on-year and by 15% since the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: http://essapharma.com
Peers: OLMA OMER ONVO ORIC

Key stats

What are the main financial stats of EPIX
Market
Shares outstanding
44.39M
Market cap
$78.57M
Enterprise value
-$14.7M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.66
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
Gross profit
$0
Operating income
-$36.51M
Net income
-$31.11M
EBIT
-$31.11M
EBITDA
-$31.02M
Free cash flow
-$22.4M
Per share
EPS
-$0.69
EPS diluted
-$0.69
Free cash flow per share
-$0.5
Book value per share
$2.68
Revenue per share
$0
TBVPS
$2.76
Balance sheet
Total assets
$122.63M
Total liabilities
$3.87M
Debt
$305,043
Equity
$118.77M
Working capital
$118.42M
Liquidity
Debt to equity
0
Current ratio
33.12
Quick ratio
32.81
Net debt/EBITDA
3.01
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-23.9%
Return on equity
-24.6%
Return on invested capital
-94.1%
Return on capital employed
-26.2%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

EPIX stock price

How has the Essa Pharma stock price performed over time
Intraday
-1.67%
1 week
-1.12%
1 month
14.19%
1 year
-71.08%
YTD
-1.12%
QTD
12.03%

Financial performance

How have Essa Pharma's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$36.51M
Net income
-$31.11M
Gross margin
N/A
Net margin
N/A
The net income has contracted by 21% YoY and by 9% from the previous quarter
EPIX's operating income is down by 15% year-on-year and by 6% since the previous quarter

Growth

What is Essa Pharma's growth rate over time

Valuation

What is Essa Pharma stock price valuation
P/E
N/A
P/B
0.66
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has decreased by 17% YoY and by 8% QoQ
The stock's price to book (P/B) is 70% less than its 5-year quarterly average of 2.2 and 65% less than its last 4 quarters average of 1.9
EPIX's equity is down by 16% year-on-year and by 4.7% since the previous quarter

Efficiency

How efficient is Essa Pharma business performance
EPIX's return on invested capital has dropped by 75% since the previous quarter
EPIX's return on assets is down by 41% year-on-year and by 14% since the previous quarter
EPIX's ROE is down by 41% YoY and by 14% from the previous quarter

Dividends

What is EPIX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for EPIX.

Financial health

How did Essa Pharma financials performed over time
EPIX's quick ratio is down by 19% year-on-year and by 15% since the previous quarter
The company's current ratio fell by 19% YoY and by 14% QoQ
The company's debt is 100% lower than its equity
The company's debt fell by 19% YoY and by 7% QoQ
EPIX's equity is down by 16% year-on-year and by 4.7% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.